PYUN970IHaveChosen
liked
1
PYUN970IHaveChosen
liked
$Cemtrex(CETX.US$ Offering closed LFG
5
PYUN970IHaveChosen
liked
$Cemtrex(CETX.US$
NEWS
Cemtrex, Inc. Announces Closing of $10 Million Upsized Underwritten Public Offering
NEWS
Cemtrex, Inc. Announces Closing of $10 Million Upsized Underwritten Public Offering
3
2
PYUN970IHaveChosen
liked
$Lexicon Pharmaceuticals(LXRX.US$ Lexicon Pharmaceuticals (NASDAQ:LXRX) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 17.65 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $1.130 million which missed the analyst consensus estimate of $1.401 million by 19.33 percent. This is a 4.61K percent increase over sales of $24.000 thousand the same period last...
1
2
PYUN970IHaveChosen
liked
$Allarity Therapeutics(ALLR.US$ This is probably one of the most abused and manipulated stocks in the market over the last 15+ months! If the SEC really wanted to show that they are not part of the crooked scheme? Well this would be a perfect ticker to do a deep and thorough investigation! If they did im have ZERO doubt of what they would find! Well that is if they would be 100% honest in their looking and reporting what they found...
4
9
PYUN970IHaveChosen
liked
$Complete Solaria(CSLR.US$
NEWS
Complete Solaria to be Self-Funded in Q2 2024
Improved gross margin of 24% in Q1’24 despite revenue drop, with Q2’24 forecast exceeding 30%.
Operational efficiency achieved through headcount reduction to 109 employees, down from 428 in June ’23.
All remaining employees granted retention stock options to bolster motivation and loyalty.
CEO transition to T.J. Rodgers to drive fundraising and M&A strategies, with a focus on financial stability.
Organizational restru...
NEWS
Complete Solaria to be Self-Funded in Q2 2024
Improved gross margin of 24% in Q1’24 despite revenue drop, with Q2’24 forecast exceeding 30%.
Operational efficiency achieved through headcount reduction to 109 employees, down from 428 in June ’23.
All remaining employees granted retention stock options to bolster motivation and loyalty.
CEO transition to T.J. Rodgers to drive fundraising and M&A strategies, with a focus on financial stability.
Organizational restru...
5
PYUN970IHaveChosen
liked
PYUN970IHaveChosen
liked
$Palisade Bio(PALI.US$ NICE. PRIVATE PLACEMENT AT 6.50. Bullish. Big news coming!!
2
PYUN970IHaveChosen
liked
$Palisade Bio(PALI.US$
NEWS
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
NEWS
Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq Rules
1
1